James E Strong

James E Strong

UNVERIFIED PROFILE

Are you James E Strong?   Register this Author

Register author
James E Strong

James E Strong

Publications by authors named "James E Strong"

Are you James E Strong?   Register this Author

29Publications

628Reads

35Profile Views

The Crux of Ebola Diagnostics.

J Infect Dis 2017 12;216(11):1340-1342

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jix490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853288PMC
December 2017

Reply to Colebunders.

Clin Infect Dis 2017 01 9;64(2):232. Epub 2016 Nov 9.

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289505PMC
January 2017

Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment Center.

J Infect Dis 2016 10 30;214(suppl 3):S145-S152. Epub 2016 Jun 30.

Public Health Agency of Canada Department of Medical Microbiology Department of Pediatrics and Child Health, University of Manitoba, Winnipeg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw198DOI Listing
October 2016

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

J Infect Dis 2015 Oct 10;212 Suppl 2:S91-7. Epub 2015 Jun 10.

Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564553PMC
October 2015

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Science 2015 Aug 6;349(6249):739-42. Epub 2015 Aug 6.

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aab3920DOI Listing
August 2015

Evaluating environmental persistence and disinfection of the Ebola virus Makona variant.

Viruses 2015 Apr 14;7(4):1975-86. Epub 2015 Apr 14.

Applied Biosafety Research Program, Canadian Science Centre for Human and Animal Health and J. C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB R3E 3P6, Canada and 745 Logan Street, Winnipeg, MB R3E 3L5, Canada.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1999-4915/7/4/1975
Publisher Site
http://dx.doi.org/10.3390/v7041975DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411685PMC
April 2015

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Nature 2014 Oct 29;514(7520):47-53. Epub 2014 Aug 29.

1] National Laboratory for Zoonotic Diseases and Special Pathogens, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada [2] Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada [3] Department of Immunology, University of Manitoba, Winnipeg, Manitoba R3E 0T5, Canada [4] Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214273PMC
October 2014

A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.

J Infect Dis 2013 Apr 9;207(8):1316-27. Epub 2013 Jan 9.

Laboratory of Virology, Division of Intramural Research, NationalInstitute of Allergy and Infectious Diseases/National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jit004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603532PMC
April 2013

Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.

PLoS One 2012 11;7(7):e39990. Epub 2012 Jul 11.

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039990PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394781PMC
March 2013

Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.

J Bioterror Biodef 2011 Oct(S1)

Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509938PMC
October 2011

Disease modeling for Ebola and Marburg viruses.

Dis Model Mech 2009 Jan-Feb;2(1-2):12-7

Laboratory for Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/dmm.000471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615158PMC
August 2009

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.

PLoS One 2009 23;4(4):e5308. Epub 2009 Apr 23.

Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005308PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669164PMC
July 2009

Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.

Proc Natl Acad Sci U S A 2008 Nov 3;105(46):17982-7. Epub 2008 Nov 3.

Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB,Canada R3E 3R2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0809698105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577702PMC
November 2008

The ecology of Ebola virus.

Trends Microbiol 2007 Sep 15;15(9):408-16. Epub 2007 Aug 15.

Special Pathogens Program, National Laboratory for Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St., Winnipeg, MB R3E 3R2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tim.2007.08.001DOI Listing
September 2007

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha.

J Infect Dis 2004 Apr 12;189(7):1164-7. Epub 2004 Mar 12.

National Microbiology Laboratory, Health Canada, and Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/382597DOI Listing
April 2004

Reovirus oncolysis of human breast cancer.

Hum Gene Ther 2002 Mar;13(5):641-52

Cancer Biology Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N 4N1 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/10430340252837233DOI Listing
March 2002